


Ask a doctor about a prescription for Nizoral
Ketoconazole
the patient.
This medicine should always be used in accordance with the description in the patient information leaflet or as directed by a doctor or pharmacist.
Nizoral in the form of a medicinal shampoo is an antifungal medicine for topical use on the skin. The medicine contains the active substance ketoconazole.
Nizoral is indicated for the treatment and prevention of the following skin diseases caused by yeast of the genus Malassezia(previously called Pityrosporum):
Before starting to use Nizoral, a doctor or pharmacist should be consulted.
A doctor should be consulted, even if the following warnings concern situations that have occurred in the past.
In the case of previous long-term topical corticosteroid treatment, in order to avoid exacerbation of disease symptoms after discontinuation of their use, a doctor will recommend gradual (over 2 to 3 weeks) withdrawal from corticosteroid treatment. If corticosteroids are stopped too quickly, the skin may react with redness and itching.
Any doubts should be clarified with a doctor.
Contact of the medicine with the eyes should be avoided. If this happens, the eyes should be rinsed with water.
Seborrhoeic dermatitis and dandruff are often accompanied by increased hair loss, which can also occur, although rarely, during the use of Nizoral.
No data available.
A doctor or pharmacist should be informed about all medicines that the patient is currently taking or has recently taken, as well as about medicines that the patient plans to take.
In pregnancy and during breastfeeding, or if there is a suspicion that the woman is pregnant or plans to become pregnant, a doctor or pharmacist should be consulted before using this medicine.
Nizoral may be used during pregnancy and breastfeeding if, in the doctor's opinion, it is absolutely necessary.
This medicine should always be used in accordance with the description in the patient information leaflet or as directed by a doctor or pharmacist.
In case of doubts, a doctor or pharmacist should be consulted.
The medicine is intended for topical use on the skin in adolescents (over 12 years of age) and adults.
Unless otherwise directed by a doctor, Nizoral is usually used as described below.
Treatment:
Pityriasis versicolor: use once a day for one day.
Seborrhoeic dermatitis and dandruff of the scalp: use twice a week for 2 to 4 weeks.
Prevention:
Seborrhoeic dermatitis and dandruff of the scalp: use once a week or once every two weeks.
In case of any further doubts about the use of this medicine, a doctor or pharmacist should be consulted.
Do not use in children under 12 years of age.
The safety and efficacy of Nizoral in infants and children under 12 years of age have not been established.
Topical use of Nizoral in accordance with the indications and method of use does not pose a risk of overdose.
In case of accidental ingestion of the medicine, a doctor should be contacted immediately.
To avoid aspiration of gastric contents, do not perform gastric lavage or induce vomiting.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
During treatment with Nizoral, the following side effects may occur:
Uncommon (in more than 1 in 1000 and less than 1 in 100 patients): at the application site, redness, irritation, hypersensitivity, itching, reaction, and pustules may occur. Uncommonly, eye irritation and increased tearing, as well as hypersensitivity, folliculitis, acne, hair loss, contact dermatitis, dryness of the skin, abnormal hair structure, rash, burning sensation, and skin disorders may occur. Rarely (in less than 1 in 1000 patients), exfoliative dermatitis and skin discoloration may occur. Very rarely (in less than 1 in 10,000 patients), urticaria, angioedema, and changes in hair color have been reported.
If any side effects occur, including any side effects not listed in this leaflet, the doctor or pharmacist should be informed. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not store above 25°C.
Store the bottle tightly closed.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. A pharmacist should be asked how to dispose of medicines that are no longer needed. This will help protect the environment.
The medicine is a pink, viscous medicinal shampoo.
Packaging:
HDPE bottle containing 120 ml of shampoo, in a cardboard box.
For more detailed information, the marketing authorization holder or parallel importer should be contacted.
Clonmel Healthcare Ltd.
Clonmel, Co. Tipperary
Ireland
Janssen Pharmaceutica NV
Turnhoutseweg 30
B-2340 Beerse
Belgium
McGregor Cory Ltd
Middleton Close, Banbury
Oxon OX16 4RS
United Kingdom
Clonmel Healthcare Ltd.
Clonmel, Co. Tipperary
Ireland
STADA Arzneimittel AG
Stadastrasse 2-18,
D-61118, Bad Vilbel
Germany
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing Authorization Number in Ireland, the Country of Export:PA 126/315/002
[Information about the trademark]
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Nizoral – subject to medical assessment and local rules.